1-3 of 3
M. Margaret Juliana
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 972–979.
https://doi.org/10.1158/1535-7163.MCT-07-2141
Published: 15 April 2008
View article titled, Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
Open the PDF for Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes in another window
Journal Articles

Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols

Ronald A. Lubet, Chung S. Yang, Mao-Jung Lee, Yukihiko Hara, Izet M. Kapetanovic, James A. Crowell, Vernon E. Steele, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (7): 2022–2028.
https://doi.org/10.1158/1535-7163.MCT-07-0058
Published: 09 July 2007
View article titled, Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols
Open the PDF for Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols in another window
Journal Articles

Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations

Ronald A. Lubet, Konstantin Christov, Ming You, Ruisheng Yao, Vernon E. Steele, David W. End, M. Margaret Juliana, Clinton J. Grubbs
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 1073–1078.
https://doi.org/10.1158/1535-7163.MCT-05-0398
Published: 28 April 2006
View article titled, Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations
Open the PDF for Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations in another window